Invesco Dorsey Wright Healthcare Momentum ETF Rating $60.30 +0.41 (+0.68%) As of 03:36 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy 2.72Holdings in PTH have an aggregate rating of Moderate Buy based on 388 analyst ratings issued in the past year covering 25 companies (66.4% of the portfolio).PTH Aggregate Price Target$60.30High Prediction$60.30Average Prediction$60.30Low Prediction$60.30Holdings in PTH have an aggregate price target of $60.30 and a range of $60.30 to $60.30 covering 25 companies (66.4% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PTH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.95%RVMDRevolution Medicines$203.99+1.0%2.4215 of 5 stars2.91$161.79 -20.7%22Analyst Forecast4.93%ROIVRoivant Sciences$36.260.0%1.61 of 5 stars2.83$35.14 -3.1%12Positive News4.81%BTSGBrightSpring Health Services$61.63+2.3%4.9455 of 5 stars3.10$70.71 14.7%20Analyst Forecast4.58%GHGuardant Health$157.07-1.5%3.2527 of 5 stars2.96$183.78 17.0%25Insider Trade4.35%AXSMAxsome Therapeutics$213.48-0.1%3.2561 of 5 stars2.82$267.60 25.4%22Earnings ReportAnalyst Forecast3.04%LQDALiquidia$74.45+3.3%4.5367 of 5 stars2.64$98.08 31.7%11Trending NewsEarnings ReportAnalyst DowngradeAnalyst RevisionGap Up2.96%ERASErasca$18.40+3.0%2.5837 of 5 stars2.64$22.09 20.1%11Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Down2.72%ORKAOruka Therapeutics$111.12+2.8%3.1811 of 5 stars2.82$134.30 20.9%11News CoverageEarnings ReportAnalyst Forecast2.33%TXG10x Genomics$55.98-3.7%1.7203 of 5 stars2.25$38.31 -31.6%16News CoverageAnalyst ForecastInsider Trade2.27%RLAYRelay Therapeutics$19.84-0.5%3.3876 of 5 stars2.86$25.83 30.2%14Analyst Forecast2.16%TVTXTravere Therapeutics$62.12+1.1%1.7657 of 5 stars2.69$61.67 -0.7%13Positive NewsAnalyst Revision2.14%TNGXTango Therapeutics$25.56-0.4%2.4101 of 5 stars2.75$43.31 69.4%16Earnings ReportAnalyst Upgrade2.14%AGLAgilon Health$96.62+8.7%0.9008 of 5 stars2.20$86.18 -10.8%15Analyst Forecast2.05%OSCROscar Health$32.68+6.2%4.4238 of 5 stars2.42$26.22 -19.8%12Analyst Upgrade2.04%ILMNIllumina$190.75-1.0%3.2259 of 5 stars2.47$188.40 -1.2%17Positive News2.03%ARWRArrowhead Pharmaceuticals$86.66+1.2%2.0281 of 5 stars2.62$97.33 12.3%132.03%SYRESpyre Therapeutics$103.91+2.0%1.7651 of 5 stars2.87$111.69 7.5%15Analyst Forecast1.97%AXGNAxoGen$48.74+1.4%2.5522 of 5 stars2.73$51.00 4.6%11Insider Trade1.96%MRNAModerna$63.28-0.6%1.3524 of 5 stars1.88$42.13 -33.4%171.93%CYTKCytokinetics$74.14+0.9%3.5587 of 5 stars2.86$102.20 37.9%21Analyst ForecastAnalyst Revision1.93%JAZZJazz Pharmaceuticals$245.03-0.3%4.1011 of 5 stars2.95$272.89 11.4%20Analyst Forecast1.80%VTRSViatris$16.23+1.2%2.5827 of 5 stars2.57$17.50 7.8%7Positive News1.76%LGNDLigand Pharmaceuticals$293.60+1.7%3.7938 of 5 stars3.00$336.57 14.6%9Analyst Upgrade1.75%HUMHumana$388.16+0.8%4.2106 of 5 stars2.43$395.22 1.8%30Trending NewsAnalyst DowngradeAnalyst Revision1.74%CORTCorcept Therapeutics$114.53+3.6%2.7753 of 5 stars2.63$119.17 4.1%8Positive NewsInsider Trade This page (NASDAQ:PTH) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Dorsey Wright Healthcare Momentum ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
